12:00 AM
Apr 01, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Lansoprazol/aspirin regulatory update

Takeda submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for a fixed-dose combination of Takeda's lansoprazol...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >